IDH1 and IDH2 Mutations in Gliomas

被引:434
|
作者
Cohen, Adam L. [1 ]
Holmen, Sheri L. [2 ]
Colman, Howard [3 ]
机构
[1] Univ Utah, Huntsman Canc Inst, Dept Internal Med, Div Med Oncol, Salt Lake City, UT 84112 USA
[2] Univ Utah, Huntsman Canc Inst, Dept Surg, Salt Lake City, UT 84112 USA
[3] Univ Utah, Huntsman Canc Inst, Dept Neurosurg, Salt Lake City, UT 84112 USA
关键词
Isocitrate dehydrogenase; Astrocytoma; Oligodendroglioma; Glioblastoma; 2-Hydroxyglutarate; Carcinogenesis; Prognosis; Mutations; INTEGRATED GENOMIC ANALYSIS; HIGH-GRADE GLIOMAS; CODON; 132; MUTATION; ISOCITRATE DEHYDROGENASE; MAFFUCCI SYNDROME; OLLIER DISEASE; IN-VIVO; GLIOBLASTOMA; TUMORS; LEUKEMIA;
D O I
10.1007/s11910-013-0345-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in isocitrate dehydrogenase (IDH) 1 and 2, originally discovered in 2008, occur in the vast majority of low-grade gliomas and secondary high-grade gliomas. These mutations, which occur early in gliomagenesis, change the function of the enzymes, causing them to produce 2-hydroxyglutarate, a possible oncometabolite, and to not produce NADPH. IDH mutations are oncogenic, although whether the mechanism is through alterations in hydroxylases, redox potential, cellular metabolism, or gene expression is not clear. The mutations also drive increased methylation in gliomas. Gliomas with mutated IDH1 and IDH2 have improved prognosis compared with gliomas with wild-type IDH. Mutated IDH can now be detected by immunohistochemistry and magnetic resonance spectroscopy. No drugs currently target mutated IDH, although this remains an area of active research.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] IDH1 and IDH2 mutations in pediatric acute leukemia
    Andersson, A. K.
    Miller, D. W.
    Lynch, J. A.
    Lemoff, A. S.
    Cai, Z.
    Pounds, S. B.
    Radtke, I.
    Yan, B.
    Schuetz, J. D.
    Rubnitz, J. E.
    Ribeiro, R. C.
    Raimondi, S. C.
    Zhang, J.
    Mullighan, C. G.
    Shurtleff, S. A.
    Schulman, B. A.
    Downing, J. R.
    LEUKEMIA, 2011, 25 (10) : 1570 - 1577
  • [22] IDH1 and IDH2 Mutations Detected by Pyrosequencing in Cholangiocarcinoma
    Voss, J. S.
    Kerr, S. E.
    Fritcher, E. G. Barr
    Highsmith, W. E.
    Zhang, J.
    Roberts, L. R.
    Gores, G. J.
    Halling, K. C.
    Kipp, B. R.
    LABORATORY INVESTIGATION, 2012, 92 : 184A - 184A
  • [23] Mutations of IDH1 and IDH2 are not frequent in Multiple Myeloma
    Langer, C.
    Ibanez, M.
    Liebisch, P.
    Zenz, T.
    Knop, S.
    Einsele, H.
    Paschka, P.
    Doehner, H.
    Doehner, K.
    ONKOLOGIE, 2011, 34 : 159 - 159
  • [24] IDH1 and IDH2 Mutations Detected by Pyrosequencing in Cholangiocarcinoma
    Voss, J. S.
    Kerr, S. E.
    Fritcher, E. G. Barr
    Highsmith, W. E.
    Zhang, J.
    Roberts, L. R.
    Gores, G. J.
    Halling, K. C.
    Kipp, B. R.
    MODERN PATHOLOGY, 2012, 25 : 184A - 184A
  • [25] Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
    Murugan, A. K.
    Alzahrani, A. S.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2022, 79
  • [26] IDH1 reactivity and mosaic IDH1 or IDH2 somatic mutations in solitary enchondroma and enchondromatosis
    Saiji, E.
    Biderbost, C. Cerato
    Berczy, M.
    Rougemont, A. -L.
    VIRCHOWS ARCHIV, 2015, 467 : S167 - S167
  • [27] IDH1 Mutations in Gliomas
    Ohgaki, Hiroko
    Watanabe, Takuya
    Nobusawa, Sumihito
    Kleihues, Paul
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05): : 559 - 559
  • [28] Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia
    Ragon, Brittany Knick
    DiNardo, Courtney D.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (06) : 537 - 546
  • [29] IDH1 and IDH2 : Founding or Progressor Mutations in Myeloid Neoplasms
    Ma, Wanlong
    De Dios, Ivan
    Funari, Vincent
    Sudarsanam, Sucha
    Jiang, Shi-Ping
    Agersborg, Sally
    Hummel, Jennifer
    Blocker, Forrest
    Albitar, Maher
    BLOOD, 2017, 130
  • [30] A Noninvasive Comparison Study between Human Gliomas with IDH1 and IDH2 Mutations by MR Spectroscopy
    Shen, Xin
    Voets, Natalie L.
    Larkin, Sarah J.
    de Pennington, Nick
    Plaha, Puneet
    Stacey, Richard
    McCullagh, James S. O.
    Schofield, Christopher J.
    Clare, Stuart
    Jezzard, Peter
    Cadoux-Hudson, Tom
    Ansorge, Olaf
    Emir, Uzay E.
    METABOLITES, 2019, 9 (02)